Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Asset Utilization Ratio: 2016-2020

Historic Asset Utilization Ratio for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to 0.19.

  • Outlook Therapeutics' Asset Utilization Ratio rose 55.89% to 0.19 in Q2 2020 from the same period last year, while for Jun 2020 it was 0.19, marking a year-over-year increase of 55.89%. This contributed to the annual value of 0.41 for FY2019, which is 187.92% up from last year.
  • Latest data reveals that Outlook Therapeutics reported Asset Utilization Ratio of 0.19 as of Q2 2020, which was down 56.51% from 0.44 recorded in Q1 2020.
  • Outlook Therapeutics' 5-year Asset Utilization Ratio high stood at 0.47 for Q4 2019, and its period low was 0.08 during Q2 2017.
  • Its 3-year average for Asset Utilization Ratio is 0.23, with a median of 0.17 in 2018.
  • In the last 5 years, Outlook Therapeutics' Asset Utilization Ratio tumbled by 45.59% in 2018 and then surged by 195.38% in 2019.
  • Quarterly analysis of 5 years shows Outlook Therapeutics' Asset Utilization Ratio stood at 0.10 in 2016, then soared by 61.83% to 0.16 in 2017, then climbed by 2.22% to 0.17 in 2018, then soared by 184.94% to 0.47 in 2019, then spiked by 55.89% to 0.19 in 2020.
  • Its last three reported values are 0.19 in Q2 2020, 0.44 for Q1 2020, and 0.47 during Q4 2019.